Greetings from CEO

Full menu
About KPS

Our Vision

Company History

Subsidiaries of KPS

Greetings from CEO

Global Network of Customers

Recycling Sector

CEO Greetings

Business Areas

Major product

Major licensing requirements

BIO Sector

Greetings from CEO of Bio Division

Our Vision

Business Area

Pipeline

OLED Sector

Greetings from CEO of OECD Division

Our Vision

Core Research Competence

Products

Investor Relations

Shareholder Information

Additional Information

Public Disclosures

Financial Information

IR Center

Customer Support

Contact

How to Find Us

Recruitment

Greetings from CEO

Welcome to the company website of KPS
My name is Ha Young Kim, a CEO of KPS CORP.

Founded in September 2000, KPS specializes in the development and supply of equipment used in the OLED display manufacturing process for display panel manufacturers based on technologies of manufacturing and control of precision equipment as well as vision technology.

Since KPS first started the development of precision stage equipment, the company succeeded in the development of ultra-precision stage equipment and has built its reputation with world-leading manufacturers as our supply references. Based on the initial success, KPS laid the groundwork for expanding the field of applications to photovoltaic equipment and LCD/OLED equipment, and the OLED mask tensioning equipment that the company supplied since 2009, succeeded in its entry to the global market through ongoing sales activities, going beyond the domestic display panel makers. Since 2014, KPS has been supplying equipment to display panel makers in Greater China

In the current trend of OLED business, facing a situation where the transition to the 8th generation of OLED capable of producing medium-sized or larger OLED panels such as tablet PCs and laptops is bound to happen, to expand our position and share in the OLED panel market, KPS continues on its journey with our commitment in R&D. We are preparing ourselves in order to develop a fine metal mask based on a new technology and grow into a world leader in the upcoming 8th-generation OECD market.

After obtaining approval for domestic marketing and sales of ‘Nerlynx’, a new drug for treatment of breast cancer, we are laying the foundation for future growth engines by obtaining licenses of liver cancer biomarkers and advancing into the area of circulating tumor cells (CTCs).

We promise that KPS will develop into a company that meet and exceed expectations through solid growth based on both businesses of IT and BT.

On behalf of the staff in KPS, I thank you for the ongoing support throughout the history of development of KPS.

Thank you



CEO, KPS CORP

Ha Young Kim

TOP